Navigation Links
Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
Date:10/22/2008

nabinoid-based pharmaceuticals."

As well, Dynamic Alert has just appointed world-renowned Medical Cannabis Research expert Dr. Robert Melamede as its newest Director and Chief Science Officer. Dr. Melamede has a Ph.D. in Molecular Biology and Biochemistry from the City University of New York. He retired as Chairman of the Biology Department at University of Colorado, Colorado Springs in 2005, where he continues to teach and research cannabinoids, cancer, and DNA repair. Dr. Melamede is recognized as a leading authority on the therapeutic uses of cannabis, and has authored or co-authored dozens of papers on a wide variety of scientific subjects. Dr. Melamede also serves on the Advisory Board of The Journal of the International Association for Cannabis as Medicine, and the Scientific Advisory Board Medical of the Marijuana Policy Advocacy Project, as well as the Scientific Advisory Board of Americans for Safe Access. Please visit http://www.youtube.com/watch?v=n31Nuj_AvTg to view one of many video speeches by Dr. Robert Melamede speaking on the effectiveness of Medical Cannabinoids.

Dynamic Alert President & CEO, Richard Cowan added, "This is truly a great step for Dynamic Alert, because this transaction and the addition of Dr. Melamede to our team will certainly expedite our plans to bring critical pharmaceutical cannabis products to market. Cannex has several innovative formulations in various stages development, including a lozenge that has just gone through informal human trials by a Canadian Compassion Society with outstanding results. We have updated our website, http://www.dynamicalertlimited.com/ to keep our shareholders informed as we progress through our plans to become a leader in pharmaceutical cannabis products."

You should not place undue reliance on forward-looking statements in this press releas
'/>"/>

SOURCE Dynamic Alert Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase
2. CardioDynamics BioZ(R) ICG Technology Integrates with General Electric Healthcares Centricity(R) Electronic Medical Record (EMR) System
3. Grid Dynamics Demonstrates Linear Scalability up to 512 Nodes with GridGain Software on Amazon EC2 Cloud
4. Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal
5. Scotland Showcased at BIO as Dynamic, Global Life Sciences Hub
6. Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis
7. Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation
8. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
9. CardioDynamics Receives Nasdaq Letter of Non-Compliance With Minimum Bid Price Requirement
10. U.S. Army Awards General Dynamics Contract for Biological Detection System Production and Support
11. Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 2Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 3Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 4Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 5Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 6Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 7Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 8Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 9Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 10Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 11Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008 12Catilin Receives Renewable Energy Award for Pilot Plant 2
Breaking Biology News(10 mins):Vermicompost from pig manure grows healthy hibiscus 2Synthetic protein mimics structure, function of metalloprotein in nature 2Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 1Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 2Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 3What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 1What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 2What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 3What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 4What Makes a University Great 3F Americans Say Renowned Faculty Top Rank Research Center are Most Important According to New Survey from IP Advocate 13483 5William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 1William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 2William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 3William Stanfield MD Is First Cleveland area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement 13481 4